Use of magnetic enrichment for detection of carcinoma cells in fluid specimens

被引:29
作者
Kielhorn, E [1 ]
Schofield, K [1 ]
Rimm, DL [1 ]
机构
[1] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
关键词
D O I
10.1002/cncr.10193
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Ascites fluid or a pleural effusion are common events in metastatic carcinoma, but they also can be associated with several other medical conditions. The standard for determination of malignancy in these situations is cytologic evaluation of these fluids. Although this method is frequently successful, there are times when it fails, even when the patient has a malignancy, either because of insufficient cells in the fluid or for other reasons. This study addresses this problem taking advantage of the recent advances in technology for detection of rare epithelial cells in liquid specimens. METHODS. The authors examined fluid specimens from 59 patients to determine the frequency of recovery of epithelial cells compared with that achieved by conventional cytopathology. The Dynal CELLection Epithelial Enrich (Dynal AS, Oslo, Norway) method was used. This method is based on immunomagnetic selection of cells binding to EpCAM antibodies. Carcinoma cells were confirmed by morphology and, when there was sufficient material, by E-cadherin staining. RESULTS. Grouping the cases by cytologic diagnosis, the authors found malignant cells using the cell enrichment assay in 11 of 12 malignant cases, 2 of 5 atypical cases, and 3 of 42 negative cases. Further investigations were conducted on the five cases that were cytologically negative or atypical but yielded epithelial cells after immunomagnetic enrichment. Four cases ultimately were proven malignant by other methods and one had incomplete follow-up. CONCLUSIONS. The new methods available for epithelial cell enrichment in liquids may be used successfully on cytologic fluid specimens and may lead to increased sensitivity for detection of malignancy, and consequently more accurate staging. (C) 2002 American Cancer Society.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 29 条
[1]  
ASCOLI V, 1995, ACTA CYTOL, V39, P613
[2]  
Bailey ME, 1996, ACTA CYTOL, V40, P1212
[3]   Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients [J].
Bostick, PJ ;
Morton, DL ;
Turner, RR ;
Huynh, KT ;
Wang, HJ ;
Elashoff, R ;
Essner, R ;
Hoon, DSB .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3238-3244
[4]   Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction [J].
Castells, A ;
Boix, L ;
Bessa, X ;
Gargallo, L ;
Piqué, JM .
BRITISH JOURNAL OF CANCER, 1998, 78 (10) :1368-1372
[5]  
COTE RJ, 1995, ANN SURG, V222, P415
[6]   Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies -: Evaluation of five epithelial markers [J].
Davidson, B ;
Risberg, B ;
Kristensen, G ;
Kvalheim, G ;
Emilsen, E ;
Bjåmer, A ;
Berner, A .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 1999, 435 (01) :43-49
[7]   Micrometastatic breast cancer cells in bone marrow at primary surgery: Prognostic value in comparison with nodal [J].
Diel, IJ ;
Kaufmann, M ;
Costa, SD ;
Holle, R ;
vonMinckwitz, G ;
Solomayer, EF ;
Kaul, S ;
Bastert, G .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (22) :1652-1658
[8]  
FRISMAN DM, 1993, MODERN PATHOL, V6, P179
[9]  
Garcia-Prats MD, 1998, HISTOPATHOLOGY, V32, P462
[10]   BER-EP4 - NEW MONOCLONAL-ANTIBODY WHICH DISTINGUISHES EPITHELIA FROM MESOTHELIA [J].
LATZA, U ;
NIEDOBITEK, G ;
SCHWARTING, R ;
NEKARDA, H ;
STEIN, H .
JOURNAL OF CLINICAL PATHOLOGY, 1990, 43 (03) :213-219